2
results found
Sunitinib (SUNI) is a small-molecule tyrosine kinase inhibitor with limited water solubility, extensive first-pass metabolism, and low oral bioavailability, restricting its therapeutic efficacy. This ...
Sunitinib
Cubosomes
Box Benkhen design
GMO
Bioavailability
Background While left-sided colon cancer (LCC) is distinct from right-sided disease, its internal heterogeneity is poorly understood. This study compares prognosis and molecular features between sigmo...
Left-sided colorectal cancer subtypes
Sigmoid colon cancer prognosis
Immune infiltration heterogeneity
SEER-TCGA integrated modeling
SinoXiv